Industry Research Reports
Global AI in Medical Imaging and Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-11-16
Pages: 151 Pages
Report ld: 5451771
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
AI in Medical Imaging and Diagnostics Market Size(US$)
CAGR 2025-2031
20.0%
Market Size,2031
USD 6,569
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global AI in Medical Imaging and Diagnostics market is projected to grow from US$ 1800 million in 2024 to US$ 6569 million by 2031, at a CAGR of 20.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
AI in Medical Imaging and Diagnostics refers to the use of computer algorithms, machine learning, deep learning, and other technologies to simulate and enhance the diagnostic work of medical professionals, helping doctors make more accurate and faster diagnostic decisions. These AI technologies analyze various forms of medical data, such as medical imaging, electronic health records, genomic data, etc., to identify disease patterns, predict disease progression, and provide personalized treatment recommendations.
The scope of AI products in medical diagnostics includes the following categories:
Medical Imaging Analysis: AI's application in medical imaging analysis is particularly widespread, especially in the processing and interpretation of X-rays, CT scans, MRIs, and ultrasound images. Through deep learning models, AI can automatically detect signs of diseases such as tumors, tuberculosis, and fractures, providing details that might be overlooked by doctors and helping in the early detection of diseases.
Genomics and Precision Medicine: AI plays an important role in the analysis of genomic data. By performing deep learning on DNA sequences, AI can help identify genetic diseases, cancer susceptibility genes, and drug responses, leading to personalized treatment and prevention strategies.
Disease Prediction and Risk Assessment: AI processes big data and uses pattern recognition to predict future health risks of patients. For example, by analyzing a patient's health history, lifestyle, and environmental factors, AI can identify individuals at risk of chronic diseases, heart disease, etc., and offer intervention recommendations.
Intelligent Decision Support Systems: AI-powered decision support systems integrate medical knowledge bases, clinical data, and patient information to assist doctors in making decisions in complex cases, reducing human errors. These systems often incorporate natural language processing (NLP) to extract key information from patients' medical records automatically.
Intelligent Health Monitoring: AI's application in smart devices is increasing, including wearable devices and smart diagnostic tools. These devices monitor patients' physiological indicators, such as heart rate, blood sugar levels, body temperature, etc., in real-time, analyzing health conditions using AI algorithms, and providing predictive health management.
With the continuous development of AI technology, the application of AI in medical diagnostics holds great potential, and the market is growing rapidly. Below is an analysis of the key opportunities and driving factors, risks, market concentration, downstream demand trends, and latest technologies in the AI medical diagnostics market.
Opportunities and Key Drivers:
Technological Advancements: Continuous innovations in AI technologies, particularly in machine learning, deep learning, and natural language processing, have significantly improved the accuracy and efficiency of medical diagnostics. In areas such as medical imaging, genomics analysis, and disease prediction, AI far exceeds traditional methods.
Data Availability: With the digitization of electronic medical records, genomic data, and medical imaging, vast amounts of data are now being effectively utilized, providing rich training data for AI algorithms. These data lay the foundation for optimizing and precisely applying AI systems.
Rising Health Management Demand: With the global aging population and the increase in chronic disease patients, the demand for personalized health management is growing. AI's applications in disease prevention, early detection, and health monitoring can improve overall health levels and reduce healthcare costs.
Risks Facing the Market:
Data Privacy and Security: AI systems need to process large amounts of medical data, which may involve patient privacy. Ensuring data security and compliance, preventing data breaches and misuse, is a significant challenge for AI medical applications.
Trustworthiness and Accuracy: While AI can provide efficient diagnostics, its accuracy still carries some risk. If AI systems fail to account for all potential factors, misdiagnosis or missed diagnoses may occur, affecting patient health and treatment outcomes.
Legal and Ethical Issues: The application of AI in medicine faces legal and ethical challenges. For example, can AI-generated diagnoses be used as a basis for medical decision-making? Who is responsible if an error occurs?
Market Concentration: Currently, the AI medical field is highly concentrated, dominated by large tech companies such as Google, IBM, and Microsoft, which have a leading edge in technology innovation and financial investment. However, as market demand increases, more startups and small to medium-sized companies are emerging in subfields like medical imaging analysis and intelligent health management, creating intense competition.
Downstream Demand Trends:
Early Diagnosis and Prevention: With increasing attention to health management, the demand for AI in early diagnosis and disease prevention is rising. Particularly in early screening for major diseases such as cancer, heart disease, and diabetes, AI plays an increasingly important role.
Personalized Treatment Plans: With the development of precision medicine, AI helps develop personalized treatment and drug selection strategies based on individual genetic and health data. Personalized healthcare will be an essential trend in the future.
Latest Technologies:
Deep Learning and Medical Imaging Analysis: Deep learning technologies are becoming more mature in medical imaging, enabling efficient and accurate detection of tumors, organ abnormalities, and other issues, assisting doctors in fast diagnoses.
Natural Language Processing (NLP) and Clinical Text Analysis: AI uses NLP technologies to automatically extract valuable information from large clinical texts, helping doctors quickly obtain patient history and symptom data during diagnosis.
AI and Robotic Surgery Integration: The integration of AI with robotic surgery technologies will advance surgical procedures, providing higher precision surgical guidance and operations.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global AI in Medical Imaging and Diagnostics market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- IBM Watson Health
- Siemens Healthineers
- GE Healthcare
- Aidoc
- Zebra Medical Vision
- PathAI
- Google Health
- Butterfly Network
- Tempus
- Arterys
- Abbott Laboratories
- Philips Healthcare
- Medtronic
- Canon Medical Systems
- Johnson & Johnson
- Nuance Communications
- Veeva Systems
- Babylon Health
- AliveCor
- Health Catalyst
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Machine Learning Models
- Natural Language Processing
- Expert Systems
- Computer Vision
- Robotics
Segment by Application
- Medical Imaging
- Pathology
- Genomic Medicine
- Clinical Decision Support Systems
- Virtual Health Assistants
- Predictive Analytics
CHAPTER OUTLINE
Chapter 1: Defines the AI in Medical Imaging and Diagnostics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to AI in Medical Imaging and Diagnostics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AI in Medical Imaging and Diagnostics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Machine Learning Models
1.2.3 Natural Language Processing
1.2.4 Expert Systems
1.2.5 Computer Vision
1.2.6 Robotics
1.3 Market Segmentation by Application
1.3.1 Global AI in Medical Imaging and Diagnostics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical Imaging
1.3.3 Pathology
1.3.4 Genomic Medicine
1.3.5 Clinical Decision Support Systems
1.3.6 Virtual Health Assistants
1.3.7 Predictive Analytics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AI in Medical Imaging and Diagnostics Revenue Estimates and Forecasts 2020-2031
2.2 Global AI in Medical Imaging and Diagnostics Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global AI in Medical Imaging and Diagnostics Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global AI in Medical Imaging and Diagnostics Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Machine Learning Models Market Size by Players
3.3.2 Natural Language Processing Market Size by Players
3.3.3 Expert Systems Market Size by Players
3.3.4 Computer Vision Market Size by Players
3.3.5 Robotics Market Size by Players
3.4 Global AI in Medical Imaging and Diagnostics Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global AI in Medical Imaging and Diagnostics Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global AI in Medical Imaging and Diagnostics Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America AI in Medical Imaging and Diagnostics Market Size by Type (2020-2031)
6.4 North America AI in Medical Imaging and Diagnostics Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America AI in Medical Imaging and Diagnostics Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe AI in Medical Imaging and Diagnostics Market Size by Type (2020-2031)
7.4 Europe AI in Medical Imaging and Diagnostics Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe AI in Medical Imaging and Diagnostics Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific AI in Medical Imaging and Diagnostics Market Size by Type (2020-2031)
8.4 Asia-Pacific AI in Medical Imaging and Diagnostics Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific AI in Medical Imaging and Diagnostics Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America AI in Medical Imaging and Diagnostics Market Size by Type (2020-2031)
9.4 Central and South America AI in Medical Imaging and Diagnostics Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America AI in Medical Imaging and Diagnostics Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa AI in Medical Imaging and Diagnostics Market Size by Type (2020-2031)
10.4 Middle East and Africa AI in Medical Imaging and Diagnostics Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa AI in Medical Imaging and Diagnostics Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 IBM Watson Health
11.1.1 IBM Watson Health Corporation Information
11.1.2 IBM Watson Health Business Overview
11.1.3 IBM Watson Health AI in Medical Imaging and Diagnostics Product Features and Attributes
11.1.4 IBM Watson Health AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.1.5 IBM Watson Health AI in Medical Imaging and Diagnostics Revenue by Product in 2024
11.1.6 IBM Watson Health AI in Medical Imaging and Diagnostics Revenue by Application in 2024
11.1.7 IBM Watson Health AI in Medical Imaging and Diagnostics Revenue by Geographic Area in 2024
11.1.8 IBM Watson Health AI in Medical Imaging and Diagnostics SWOT Analysis
11.1.9 IBM Watson Health Recent Developments
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Corporation Information
11.2.2 Siemens Healthineers Business Overview
11.2.3 Siemens Healthineers AI in Medical Imaging and Diagnostics Product Features and Attributes
11.2.4 Siemens Healthineers AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.2.5 Siemens Healthineers AI in Medical Imaging and Diagnostics Revenue by Product in 2024
11.2.6 Siemens Healthineers AI in Medical Imaging and Diagnostics Revenue by Application in 2024
11.2.7 Siemens Healthineers AI in Medical Imaging and Diagnostics Revenue by Geographic Area in 2024
11.2.8 Siemens Healthineers AI in Medical Imaging and Diagnostics SWOT Analysis
11.2.9 Siemens Healthineers Recent Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Corporation Information
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare AI in Medical Imaging and Diagnostics Product Features and Attributes
11.3.4 GE Healthcare AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.3.5 GE Healthcare AI in Medical Imaging and Diagnostics Revenue by Product in 2024
11.3.6 GE Healthcare AI in Medical Imaging and Diagnostics Revenue by Application in 2024
11.3.7 GE Healthcare AI in Medical Imaging and Diagnostics Revenue by Geographic Area in 2024
11.3.8 GE Healthcare AI in Medical Imaging and Diagnostics SWOT Analysis
11.3.9 GE Healthcare Recent Developments
11.4 Aidoc
11.4.1 Aidoc Corporation Information
11.4.2 Aidoc Business Overview
11.4.3 Aidoc AI in Medical Imaging and Diagnostics Product Features and Attributes
11.4.4 Aidoc AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.4.5 Aidoc AI in Medical Imaging and Diagnostics Revenue by Product in 2024
11.4.6 Aidoc AI in Medical Imaging and Diagnostics Revenue by Application in 2024
11.4.7 Aidoc AI in Medical Imaging and Diagnostics Revenue by Geographic Area in 2024
11.4.8 Aidoc AI in Medical Imaging and Diagnostics SWOT Analysis
11.4.9 Aidoc Recent Developments
11.5 Zebra Medical Vision
11.5.1 Zebra Medical Vision Corporation Information
11.5.2 Zebra Medical Vision Business Overview
11.5.3 Zebra Medical Vision AI in Medical Imaging and Diagnostics Product Features and Attributes
11.5.4 Zebra Medical Vision AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.5.5 Zebra Medical Vision AI in Medical Imaging and Diagnostics Revenue by Product in 2024
11.5.6 Zebra Medical Vision AI in Medical Imaging and Diagnostics Revenue by Application in 2024
11.5.7 Zebra Medical Vision AI in Medical Imaging and Diagnostics Revenue by Geographic Area in 2024
11.5.8 Zebra Medical Vision AI in Medical Imaging and Diagnostics SWOT Analysis
11.5.9 Zebra Medical Vision Recent Developments
11.6 PathAI
11.6.1 PathAI Corporation Information
11.6.2 PathAI Business Overview
11.6.3 PathAI AI in Medical Imaging and Diagnostics Product Features and Attributes
11.6.4 PathAI AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.6.5 PathAI Recent Developments
11.7 Google Health
11.7.1 Google Health Corporation Information
11.7.2 Google Health Business Overview
11.7.3 Google Health AI in Medical Imaging and Diagnostics Product Features and Attributes
11.7.4 Google Health AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.7.5 Google Health Recent Developments
11.8 Butterfly Network
11.8.1 Butterfly Network Corporation Information
11.8.2 Butterfly Network Business Overview
11.8.3 Butterfly Network AI in Medical Imaging and Diagnostics Product Features and Attributes
11.8.4 Butterfly Network AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.8.5 Butterfly Network Recent Developments
11.9 Tempus
11.9.1 Tempus Corporation Information
11.9.2 Tempus Business Overview
11.9.3 Tempus AI in Medical Imaging and Diagnostics Product Features and Attributes
11.9.4 Tempus AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.9.5 Tempus Recent Developments
11.10 Arterys
11.10.1 Arterys Corporation Information
11.10.2 Arterys Business Overview
11.10.3 Arterys AI in Medical Imaging and Diagnostics Product Features and Attributes
11.10.4 Arterys AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Corporation Information
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories AI in Medical Imaging and Diagnostics Product Features and Attributes
11.11.4 Abbott Laboratories AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.11.5 Abbott Laboratories Recent Developments
11.12 Philips Healthcare
11.12.1 Philips Healthcare Corporation Information
11.12.2 Philips Healthcare Business Overview
11.12.3 Philips Healthcare AI in Medical Imaging and Diagnostics Product Features and Attributes
11.12.4 Philips Healthcare AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.12.5 Philips Healthcare Recent Developments
11.13 Medtronic
11.13.1 Medtronic Corporation Information
11.13.2 Medtronic Business Overview
11.13.3 Medtronic AI in Medical Imaging and Diagnostics Product Features and Attributes
11.13.4 Medtronic AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.13.5 Medtronic Recent Developments
11.14 Canon Medical Systems
11.14.1 Canon Medical Systems Corporation Information
11.14.2 Canon Medical Systems Business Overview
11.14.3 Canon Medical Systems AI in Medical Imaging and Diagnostics Product Features and Attributes
11.14.4 Canon Medical Systems AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.14.5 Canon Medical Systems Recent Developments
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Corporation Information
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson AI in Medical Imaging and Diagnostics Product Features and Attributes
11.15.4 Johnson & Johnson AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.15.5 Johnson & Johnson Recent Developments
11.16 Nuance Communications
11.16.1 Nuance Communications Corporation Information
11.16.2 Nuance Communications Business Overview
11.16.3 Nuance Communications AI in Medical Imaging and Diagnostics Product Features and Attributes
11.16.4 Nuance Communications AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.16.5 Nuance Communications Recent Developments
11.17 Veeva Systems
11.17.1 Veeva Systems Corporation Information
11.17.2 Veeva Systems Business Overview
11.17.3 Veeva Systems AI in Medical Imaging and Diagnostics Product Features and Attributes
11.17.4 Veeva Systems AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.17.5 Veeva Systems Recent Developments
11.18 Babylon Health
11.18.1 Babylon Health Corporation Information
11.18.2 Babylon Health Business Overview
11.18.3 Babylon Health AI in Medical Imaging and Diagnostics Product Features and Attributes
11.18.4 Babylon Health AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.18.5 Babylon Health Recent Developments
11.19 AliveCor
11.19.1 AliveCor Corporation Information
11.19.2 AliveCor Business Overview
11.19.3 AliveCor AI in Medical Imaging and Diagnostics Product Features and Attributes
11.19.4 AliveCor AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.19.5 AliveCor Recent Developments
11.20 Health Catalyst
11.20.1 Health Catalyst Corporation Information
11.20.2 Health Catalyst Business Overview
11.20.3 Health Catalyst AI in Medical Imaging and Diagnostics Product Features and Attributes
11.20.4 Health Catalyst AI in Medical Imaging and Diagnostics Revenue and Gross Margin (2020-2025)
11.20.5 Health Catalyst Recent Developments
12 AI in Medical Imaging and DiagnosticsIndustry Chain Analysis
12.1 AI in Medical Imaging and Diagnostics Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AI in Medical Imaging and Diagnostics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AI in Medical Imaging and Diagnostics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Global AI in Medical Imaging and Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI in Medical Imaging and Diagnostics market size was US$ 2200 million in 2025 and is forecast to reach a readjusted size of US$ 7752 million by 2032 with a CAGR of 20.0% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 109
USD 4250.00
(Single User License)
AI in Medical Imaging and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ 2200 million in 2025 and is projected to reach US$ 7752 million, growing at a CAGR of 20.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 139
USD 3950.00
(Single User License)
Global AI in Medical Imaging and Diagnostics Market Research Report 2026
The global AI in Medical Imaging and Diagnostics market was valued at US$ 2200 million in 2025 and is anticipated to reach US$ 7752 million by 2032, at a CAGR of 20.0% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 123
USD 2900.00
(Single User License)
Global AI in Medical Imaging and Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI in Medical Imaging and Diagnostics market size was US$ 1800 million in 2024 and is forecast to a readjusted size of US$ 6569 million by 2031 with a CAGR of 20.0% during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 104
USD 4250.00
(Single User License)
AI in Medical Imaging and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ 1800 million in 2024 and is forecast to a readjusted size of US$ 6569 million by 2031 with a CAGR of 20.0% during the forecast period 2025-2031.
Published Date: 2025-02-22
Pages: 140
USD 3950.00
(Single User License)
Global AI in Medical Imaging and Diagnostics Market Insights, Forecast to 2031
Valued at US$ 2200 million in 2024, the global AI in Medical Imaging and Diagnostics market is forecast to reach US$ 6569 million by 2030, at a CAGR of 20.0% during the forecast period.
Published Date: 2025-02-22
Pages: 150
USD 4900.00
(Single User License)
Global AI in Medical Imaging and Diagnostics Market Research Report 2025
The global market for AI in Medical Imaging and Diagnostics was valued at US$ 1800 million in the year 2024 and is projected to reach a revised size of US$ 6569 million by 2031, growing at a CAGR of 20.0% during the forecast period.
Published Date: 2025-02-22
Pages: 96
USD 2900.00
(Single User License)
Global AI in Medical Imaging and Diagnostics Market Insights, Forecast to 2030
Market Analysis and Insights: Global AI in Medical Imaging and Diagnostics Market
Published Date: 2024-04-12
Pages: 114
USD 4900.00
(Single User License)
Global AI in Medical Imaging and Diagnostics Market Research Report 2024
The global AI in Medical Imaging and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 94
USD 2900.00
(Single User License)
AI in Medical Imaging and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-07
Pages: 124
USD 3950.00
(Single User License)
Global AI in Medical Imaging and Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI in Medical Imaging and Diagnostics market size was US$ 2200 million in 2025 and is forecast to reach a readjusted size of US$ 7752 million by 2032 with a CAGR of 20.0% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 109
USD 4250.00 (Single User License)AI in Medical Imaging and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ 2200 million in 2025 and is projected to reach US$ 7752 million, growing at a CAGR of 20.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 139
USD 3950.00 (Single User License)Global AI in Medical Imaging and Diagnostics Market Research Report 2026
The global AI in Medical Imaging and Diagnostics market was valued at US$ 2200 million in 2025 and is anticipated to reach US$ 7752 million by 2032, at a CAGR of 20.0% from 2026 to 2032.
Published: 2026-03-06
Pages: 123
USD 2900.00 (Single User License)Global AI in Medical Imaging and Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI in Medical Imaging and Diagnostics market size was US$ 1800 million in 2024 and is forecast to a readjusted size of US$ 6569 million by 2031 with a CAGR of 20.0% during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 104
USD 4250.00 (Single User License)AI in Medical Imaging and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ 1800 million in 2024 and is forecast to a readjusted size of US$ 6569 million by 2031 with a CAGR of 20.0% during the forecast period 2025-2031.
Published: 2025-02-22
Pages: 140
USD 3950.00 (Single User License)Global AI in Medical Imaging and Diagnostics Market Insights, Forecast to 2031
Valued at US$ 2200 million in 2024, the global AI in Medical Imaging and Diagnostics market is forecast to reach US$ 6569 million by 2030, at a CAGR of 20.0% during the forecast period.
Published: 2025-02-22
Pages: 150
USD 4900.00 (Single User License)Global AI in Medical Imaging and Diagnostics Market Research Report 2025
The global market for AI in Medical Imaging and Diagnostics was valued at US$ 1800 million in the year 2024 and is projected to reach a revised size of US$ 6569 million by 2031, growing at a CAGR of 20.0% during the forecast period.
Published: 2025-02-22
Pages: 96
USD 2900.00 (Single User License)Global AI in Medical Imaging and Diagnostics Market Insights, Forecast to 2030
Market Analysis and Insights: Global AI in Medical Imaging and Diagnostics Market
Published: 2024-04-12
Pages: 114
USD 4900.00 (Single User License)Global AI in Medical Imaging and Diagnostics Market Research Report 2024
The global AI in Medical Imaging and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 94
USD 2900.00 (Single User License)AI in Medical Imaging and Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI in Medical Imaging and Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-07
Pages: 124
USD 3950.00 (Single User License)
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now